Home > Drug Search >
  • Status: IND Filing
  •   > 
Drug Filter
Category:
chemistry (66) biology (25)
Clinical Stage:
Pending (2) Active (55)
Company:
Hansoh Pharma (1) Jiangsu Hengrui Medicine (3) Merck Serono (1) Roche (1) Sanofi (1) Simcere (1) Sinopharm A-THINK Pharmaceutical (1) WuXi AppTec (2) Pharmavan (1) Zhongsheng Pharmacy (3) Shanghai Junshi Biosciences (1) 武汉华鑫康源生物医药(湖北) (1) Shanghai Henlius Biotech (2) Livzon Group (2) Sinocelltech (2) 迈博太科药业 (1) Hualan Biological Engineering (1) Liaoning Haisike pharmaceutical (1) Hisun Pharm (3) Hangzhou Zhongmei Huadong Pharmaceutical (1) Kelun Pharmaceutical (1) Sichuan Haisco Pharmaceutical (1) Penglai Nuokang Pharmaceutical (1) Zhaoke Pharmaceutical (1) XuanZhu Pharma (1) Suzhou Sirnaomics Biopharmaceuticals (1) Nanjing Zhongrui Medcine (1) Sichuan Kelunbotai Biopharmaceutical/四川科伦博泰生物医药 (1) Beijing Fengshuo Weikang (1) Baiyunshan Pharmaceutical (1) Zhejiang Yongning Pharmaceutical (2) Ningbo Ziyuan Pharmaceutical (1) Beijing Mabworks Biotech (3) Eastern Biotech (2) Bossan (1) Chongqing University of Arts and Sciences (1) Tianjin Institute of Pharmaceutical Research (1) Jianfeng Pharmaceutical (1) Shandong Luoxin Pharmaceutical (1) 成都康弘生物科技 (1) Nanjing Advenchen Laboratories (1) Zai Lab (1) China State Institute of Pharmaceutical Industry (CSIPI) (1) Shanghai Genomics (1) Institute of Materia Medica Chinese Academy of Medical Sciences (1) AMMS (1) Eleven (1) Institute of Pharmacology & Toxicology of AMMS (2) Tianjin Hemay Biotech (1) Shanghai Institute of Materia Medica, Chinese Academy of Sciences (3) HEC Pharm (2) Huadong Medicine (1) Shanghai Haihe Pharmaceutical (1) ImQuest BioSciences (1) Shenyang Pharmaceutical University (1) 302 Military Hospital of China (1) The Second Military Medical University (1) Third Military Medical University (1) National institutes of pharmaceutical Research and Development (NIP) (1) Tasly Pharm (1) Chinese PLA General Hospital/Medical School of Chinese PLA (1) Sirnaomics (1) Guangzhou Xiangxue Pharmaceuticals (1) Shandong Provincial Institute of Dermatology and Venereology (1) Hangzhou Pharmavaxin (1) Guangzhou Yinnuo Pharmaceutical (1) Fujian Jinshon Biologicalpharmaceutical (1) Hangzhou Adamerck Pharmlabs (2) Shanghai Newsummit Biopharma (2) Shanghai Xianfu Chemical Technology (1) Ocean University of China (1) Qingdao Huanghai Pharmaceutical (1) Nanjing Tech University (1) 浙江浙北药业 (1) Innocare (1) Zhejiang Forever Medicine (1) Foreland Pharma (1) Jingfeng Pharma (1) Hangzhou Advenchen Laboratories (1) Ningbo Shengjian (1) Chongqing Fujin Biomedical (1) Dalian Dien Biological Engineering (1) Anke Biotechnology (2) NuoKang Biopharma (1) Beijing Ruiyunhai Biotechnology (1) China Shijiazhuang Pharmaceutical Group/CSPC (1) Epicept (1) Zhejiang University (1) BCN Peptides (1) DiverDrugs (1) Puyi chemical/Gyrochem (1) Signum Dermalogix (1) Dermata (1) Haisco Pharmaceutical Group (1) Shanghai Bajiayi Pharmaceutical Technology (1) Beijing Molike Technology (1) Chengdu Yiping Pharmaceutical Technology (1) Sichuan Yibin Wuliangye Yibin Pharmaceutical (1) Qingdao University (1) Wuhan Kangliyuan (1) Techfields Pharma (1) Yene Pharma (1) Beijing Collab Pharma (1) Beijing Zhongyuan Hengkang Biotechnology (1) Samjin (1) Gmax Biopharm (1) Shanghai Allist Pharmaceuticals (1) Chiatai Tianqing (CTTQ) (5)
Indication:
Acne (2) Alzheimer's disease (AD) (2) Brain ischemia (1) Breast cancer (6) Keratitis (1) Chronic lymphocytic leukemia (CLL) (1) Chronic pain (1) Circulation disturbance (1) Anaplastic lymphoma kinase (ALK)-positive NSCLC (1) Depression (1) Diabetic macular edema (1) Duodenal ulcer (1) Endometrial cancer (1) Erectile dysfunction (ED) (1) Erosive esophagitis (EE) (1) Gastric cancer (2) Gastroesophageal reflux disease (GERD) (1) Glioblastoma multiforme (1) Gram-positive and Gram-negative bacterial infections (1) HCV infection (2) HIV infection (2) Hyperlipidemia (1) Idiopathic pulmonary fibrosis (IPF) (1) Inflammatory bowel disease (1) Lung cancer (1) Malignancies (2) Melanoma (1) Metastatic colorectal cancer (CRC) (1) Myocardial infarction (MI) (2) Non small cell lung cancer (NSCLC) (7) Non-alcoholic fatty liver disease (NAFLD) (1) Non-Hodgkin’s lymphoma (NHL) (1) Obesity (1) Osteoarthritis (OA) (2) Ovarian cancer (1) Pancreatic cancer (2) Parkinson's disease (PD) (2) Psoriasis (1) Pulmonary arterial hypertension (1) Rheumatoid arthritis (RA) (9) Solid tumours (10) Stable plaque psoriasis (1) Systemic lupus erythematosus (3) Type 2 diabetes (5) Uveitis (1) Venous thromboembolism (VTE) (1) Cardiac ischemic complications (1) Colorectal cancer (1) Ankylosing Spondylitis (AS) (1) Systemic bacterial infections (3) Chronic heart failure (1) Pain (1) Anesthesia (1) Cervical carcinoma (1) Bone metastases from solid tumors (1) HER2-positive metastatic breast cancer (2) Renal carcinoma (1) Hematological cancer (1) Hyperphosphatemia (1) Gastrointestinal motility disorders (1) Ischemic stroke (2) Plaque psoriasis (1) Gout (1) Thrombosis (2) Alopecia (1) Diffuse large B cell lymphoma (3) Skin hypertrophic scars (1) Urinary tract stones (1) Non-erosive Relux Disease (1) Liver cancer (1) Liver failure (1) hematological malignancies (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 4 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top